Peptide ProvidersDirect
Reform ABQ logo
Unclaimed10 services cataloged

Reform ABQ

Albuquerque, NM · In-person care

Visit provider website ↗

Provider overview

About Reform ABQ

Reform ABQ publishes one Albuquerque clinic and describes itself as a nurse-practitioner-led primary-care practice for adults and children. Its current peptide page provides unusually explicit cautions about investigational, off-label, and compounded therapies, and describes medical evaluation, laboratory testing when appropriate, informed discussion, monitoring, and follow-up. The catalog includes compounded GLP-1 medications and several named wellness peptides. Those names and proposed uses remain provider-published and do not establish approval, lawful compounding availability, formulation, pharmacy identity, safety, effectiveness, or patient eligibility.

At a glance

Market role
Direct patient-care provider
Care model
In person
Coverage
1 listed jurisdictions
Pharmacy pathway
Not publicly established
Medical weight managementHormone healthLongevity medicineMetabolic healthLaboratory testing

503A and 503B labels describe statutory compounding pathways or public relationships. They do not mean a compounded drug is FDA-approved or that FDA endorses a facility.

Service catalog

Programs and services

Provider-advertised services, grouped for quick scanning with all details visible.

10 cataloged
01

Provider-advertised peptide therapy

1

Medical peptide evaluation and monitoring

The published pathway includes a medical evaluation, individualized selection, laboratory monitoring when appropriate, informed discussion, and follow-up.

Provider source ↗
02

Provider-advertised investigational compounds

1

BPC-157

BPC-157 appears in the current catalog with an express statement that many wellness peptides are investigational or used off label.

Provider source ↗
03

Provider-advertised growth-hormone-related care

1

CJC-1295 with ipamorelin

This combination appears in the current catalog; approval, compoundability, safety, and availability are not inferred.

Provider source ↗
04

Provider-advertised metabolic compounds

1

AOD-9604 and ibutamoren

These names appear in the current peptide materials with provider-published regulatory cautions.

Provider source ↗
05

Sexual health

1

PT-141

PT-141 is listed for selected sexual-wellness concerns after individualized assessment.

Provider source ↗
06

Medical weight management

1

Compounded semaglutide and tirzepatide pathways

The clinic advertises compounded GLP-1 and GLP-1/GIP medications when clinically appropriate and legally permissible.

Provider source ↗
07

Hormone health

2

Testosterone replacement

Men's testosterone evaluation and replacement care appear in the active service catalog.

Provider source ↗

Hormone care for women

The clinic advertises individualized hormone-replacement services for women.

Provider source ↗
08

Laboratory services

1

Laboratory testing and monitoring

The peptide page lists metabolic, hormone, hematology, thyroid, and pancreatic laboratory markers that may be used when appropriate.

Provider source ↗
09

Primary and integrative care

1

Adult and pediatric primary care

The practice provides preventive, acute, and chronic-condition primary care for adults and children.

Provider source ↗
Important: Inclusion does not establish availability for every patient or state, regulatory status, clinical appropriateness, safety, or effectiveness.

Coverage and research

Explore this provider’s markets

Review every state page this provider advertises serving, then use the related guides to evaluate services and claims.

New Mexico
Sermorelin research guide →Lab testing in peptide programs →Researching longevity claims →

Continue comparing

Related provider profiles

Anderson Longevity ClinicDefy MedicalAnazaoHealth

Evidence

Sources reviewed

Logo reproduced from the provider’s official website for identification. Logo source ↗

These links support the public facts recorded here. Provider-published information is not an independent endorsement.